M. Scott Salka
Chief Executive Officer bei Vesper Biologics, Inc.
Profil
M.
Scott Salka is the founder of Ambit Biosciences Corp.
(founded in 2001) and Rakuten Medical, Inc. (founded in 2010).
He is also the founder of Sequana Therapeutics, Inc. Mr. Salka's current jobs include Chief Executive Officer positions at Vesper Biologics, Inc., CendR, Inc., and Arog Pharmaceuticals, Inc. where he holds the title of Co-Chief Executive Officer & Director.
He also holds Director positions at San Diego State University and BIOCOM, and a Director position at SDSU College of Business Administration.
Mr. Salka's former jobs include Chief Executive Officer & Director positions at AmpliPhi Biosciences Corp., Arcaris, Inc., and 454 Life Sciences Corp.
He also held the position of Independent Director at Sorrento Therapeutics, Inc. Additionally, he held Principal positions at Goodrich Corp., Unisys Corp., Roche Diagnostics GmbH, Boehringer Ingelheim Corp., and Parke, Davis & Co. LLC.
Mr. Salka received an MBA degree from Carnegie Mellon University and an undergraduate degree from San Diego State University.
Aktive Positionen von M. Scott Salka
| Unternehmen | Position | Beginn |
|---|---|---|
| Vesper Biologics, Inc. | Chief Executive Officer | - |
| CendR, Inc. | Chief Executive Officer | - |
| San Diego State University | Director/Board Member | 01.01.2009 |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Director/Board Member | 01.01.2007 |
| SDSU College of Business Administration | Director/Board Member | - |
Arog Pharmaceuticals, Inc.
 Arog Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arog Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology. It offers clinical trials for Acute Myeloid Leukemia, Gastrointestinal Stromal Tumor, and Glioma. The company was founded by Vinay K. Jain in 2010 and is headquartered in Dallas, TX. | Chief Executive Officer | 01.03.2018 |
Ehemalige bekannte Positionen von M. Scott Salka
| Unternehmen | Position | Ende |
|---|---|---|
MorphImmune, Inc.
 MorphImmune, Inc. BiotechnologyHealth Technology MorphImmune, Inc. is a biotechnology company that specializes in developing targeted oncology therapeutics. MorphImmune is based in West Lafayette, IN and has been led by CEO Clay B. Siegall since 2023. The company's proprietary targeted effector platform delivers payloads to diseased cells, reducing toxicity and increasing efficacy of known effector molecules. The company was founded on the research of Philip S. Low, Ph.D., the Presidential Scholar for Drug Discovery and Ralph C. Corley Distinguished Professor of Chemistry at Purdue University. | Chief Executive Officer | 12.04.2021 |
AmpliPhi Biosciences Corp.
 AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Chief Executive Officer | 31.05.2017 |
Rakuten Medical, Inc.
 Rakuten Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Rakuten Medical, Inc. operates as a clinical stage biotechnology company which develops tumor-targeted precision therapies. It develops new anticancer therapies based on the photoimmunotherapy platform. The company was founded in 2010 and is headquartered in San Diego, CA. | Chief Executive Officer | 01.05.2015 |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von M. Scott Salka
| Carnegie Mellon University | Masters Business Admin |
| San Diego State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| UNISYS CORPORATION | Technology Services |
| SORRENTO THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 15 |
|---|---|
Goodrich Corp.
 Goodrich Corp. Aerospace & DefenseElectronic Technology Goodrich Corp. engages in the supply of systems and services to the aerospace, defense and homeland security markets. The company was founded by Benjamin Franklin Goodrich in 1870 and is headquartered in Charlotte, NC. | Electronic Technology |
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Health Technology |
Sequana Therapeutics, Inc.
 Sequana Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sequana Therapeutics Inc. is a leading genomics company that uses industrial-scale gene-finding technologies and functional genomics to develop products aimed at diagnosing and treating common human diseases | Commercial Services |
Ambit Biosciences Corp.
 Ambit Biosciences Corp. Pharmaceuticals: MajorHealth Technology Ambit Biosciences Corp. develops pharmaceutical drugs. It engages in discovery, development and commercialization of small-molecule kinase inhibitors for the treatment of cancer. The firm provides drug to treat unmet medical needs in oncology, autoimmune and inflammatory diseases. The company was founded on May 17, 2000 and is headquartered in San Diego, CA. | Health Technology |
Arcaris, Inc.
 Arcaris, Inc. Miscellaneous Commercial ServicesCommercial Services Arcaris, Inc. develops genetic, proteomic, and cell biological systems for direct identification and validation of novel drug targets. The company is headquartered in Salt Lake City, UT. | Commercial Services |
Roche Diagnostics GmbH
 Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the private company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Commercial Services |
454 Life Sciences Corp.
 454 Life Sciences Corp. Medical/Nursing ServicesHealth Services 454 Life Sciences Corp. engages in the provision of medical testing services to determine the nucleotide sequence of whole genomes. The company was founded by Jonathan M. Rothberg in 2000 and is headquartered in Branford, CT. | Health Services |
BIOCOM
BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Commercial Services |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Health Technology |
| Parke, Davis & Co. LLC | |
| Vesper Biologics, Inc. | |
| CendR, Inc. | |
Arog Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arog Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology. It offers clinical trials for Acute Myeloid Leukemia, Gastrointestinal Stromal Tumor, and Glioma. The company was founded by Vinay K. Jain in 2010 and is headquartered in Dallas, TX. | Health Technology |
Rakuten Medical, Inc.
Rakuten Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Rakuten Medical, Inc. operates as a clinical stage biotechnology company which develops tumor-targeted precision therapies. It develops new anticancer therapies based on the photoimmunotherapy platform. The company was founded in 2010 and is headquartered in San Diego, CA. | Commercial Services |
MorphImmune, Inc.
MorphImmune, Inc. BiotechnologyHealth Technology MorphImmune, Inc. is a biotechnology company that specializes in developing targeted oncology therapeutics. MorphImmune is based in West Lafayette, IN and has been led by CEO Clay B. Siegall since 2023. The company's proprietary targeted effector platform delivers payloads to diseased cells, reducing toxicity and increasing efficacy of known effector molecules. The company was founded on the research of Philip S. Low, Ph.D., the Presidential Scholar for Drug Discovery and Ralph C. Corley Distinguished Professor of Chemistry at Purdue University. | Health Technology |
